A survey of psychotropic drug prescriptions in an oncology population

The present study examined the prescription practices concerning psychotropic drugs in 5 major oncology centers over a 6 month period. During the survey period 1579 patients were admitted to the collaborating institutions, and 51% of them were prescribed at least one psychotropic medication. Hypnoti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1979-11, Vol.44 (5), p.1919-1929
Hauptverfasser: Derogatis, Leonard R., Feldstein, Michael, Melisaratos, Nick, Morrow, Gary, Schmale, Arthur, Schmitt, Madeline, Gates, Christopher, Murawski, Benjamin, Holland, Jimmie, Penman, Doris, Enelow, Allen J., Adler, Leta Mckinney
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present study examined the prescription practices concerning psychotropic drugs in 5 major oncology centers over a 6 month period. During the survey period 1579 patients were admitted to the collaborating institutions, and 51% of them were prescribed at least one psychotropic medication. Hypnotics were the most frequently prescribed drugs, accounting for 48% of total prescriptions, followed by anti‐psychotics at 26% and anti‐anxiety agents at 25%. Anti‐depressant drugs accounted for only 1% of psychotropic prescriptions. Analysis of prescription rationales revealed that 44% of the psychotropic prescriptions were written for sleep, while 25% were given for nausea and vomiting; approximately 17% were attributed to psychological distress, and 12% were associated with diagnostic medical procedures. The overall rate of prescription was approximately 2 psychotropic drugs per patient per admission, with only 2% of prescriptions resulting in chart‐documented side effects. At the level of individual compounds, 3 distinct drugs accounted for 72% of total prescriptions—flurazepam (33%), prochlorperazine (21%), and diazepam (17%).
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(197911)44:5<1919::AID-CNCR2820440555>3.0.CO;2-T